{"nct_id":"NCT04919811","title":"Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC","status":"RECRUITING","status_verified_date":"2024-11","start_date":"2021-09-01","start_date_type":"ACTUAL","primary_completion_date":"2025-06","primary_completion_date_type":"ESTIMATED","completion_date":"2027-06","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NUVB"]}